LATEST ARTICLES
Lilly claims promising finding in failed study of COVID-19 drug
With new data, Merck could be first to bring immunotherapy to early kidney cancer
Biogen adds a late-stage prospect to its growing biosimilar business
Gilead wins full approval for drug acquired in Immunomedics deal
AstraZeneca’s coronavirus vaccine possibly linked to rare blood clots, EMA says
FibroGen admits misleading safety data for anemia drug, dimming prospects
NLSDays goes digital for 2021 and is set to welcome key players in the life science industry from across the globe
Metrion Biosciences closes £2.7m new equity financing
UniQure says hemophilia gene therapy likely not cause of study volunteer’s cancer
Amgen acquires a small biotech and its inflammatory disease research
Home
CURRENT FEATURES
Editorial Archive
Volume 3 Issue 3
Volume 3 Issue 2
Volume 3 Issue 1
Volume 2 Issue 4
Volume 2 Issue 3
Volume 2 Issue 2
Volume 2 Issue 1
Volume 1 Issue 3
Volume 1 Issue 2
Volume 1 Issue 1
ARCHIVED ISSUES
Events
Company Profile
Sponsored Articles
news
Clinical Trials Advisor
Drug Industry Daily
Drug GMP Report
Manufacturing & Packaging
Discovery & Development
eBooks
Podcast
Search
Close
Home
CURRENT FEATURES
Editorial Archive
Volume 3 Issue 3
Volume 3 Issue 2
Volume 3 Issue 1
Volume 2 Issue 4
Volume 2 Issue 3
Volume 2 Issue 2
Volume 2 Issue 1
Volume 1 Issue 3
Volume 1 Issue 2
Volume 1 Issue 1
ARCHIVED ISSUES
Events
Company Profile
Sponsored Articles
news
Clinical Trials Advisor
Drug Industry Daily
Drug GMP Report
Manufacturing & Packaging
Discovery & Development
eBooks
Podcast
Current Edition
Sorry, we couldn't find any posts. Please try a different search.